This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tel Aviv University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Work of Dikla Ben-Shushan
Introduction
Dikla Ben-Shushan is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biomedical engineering, particularly in the development of tumor models. His innovative approach combines synthetic materials with biological elements to create advanced models for cancer research.
Latest Patents
Dikla Ben-Shushan holds a patent for a groundbreaking invention titled "Three-dimensional tumor models, methods of manufacturing same and uses thereof." This patent describes a three-dimensional (3D) model of a tumor made from synthetic materials and various cell types, including both malignant and non-malignant cells. The model is designed to have a full HLA match, ensuring high compatibility with a 3D image of the tumor. The methods for forming this 3D tumor model include bioprinting techniques, and the system allows for perfusion and fluid connection to a medium containing immune cells and other factors present in the tumor's microenvironment. This invention has potential applications in personalized therapy.
Career Highlights
Dikla is associated with Ramot at Tel Aviv University Ltd., where he continues to advance his research and development efforts. His work is pivotal in enhancing the understanding of tumor behavior and treatment responses.
Collaborations
Dikla collaborates with esteemed colleagues, including Ronit Satchi-Fainaro and Lena Neufeld, who contribute to the multidisciplinary approach of his research.
Conclusion
Dikla Ben-Shushan's innovative contributions to the field of tumor modeling represent a significant advancement in cancer research. His work not only enhances the understanding of tumors but also paves the way for personalized therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
